EUVIMEDEUVIMED entdecken
Open Access

Mechanisms of TGF-β-Induced Differentiation in Human Vascular Smooth Muscle Cells

Yuefeng Tang, Xuehui Yang, Robert E Friesel, Calvin P H Vary, Lucy Liaw

Journal of Vascular Research · 2011 · 48 (6) · 485-494

DOI: 10.1159/000327776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Research, online erschienen am 11.08.2011. Verfasst von Yuefeng Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME 04074, USA. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transforming growth factor-β (TGF-β) plays an important role in vascular homeostasis through effects on vascular smooth muscle cells (SMC). Fine-tuning of TGF-β signaling occurs at the level of ALK receptors or Smads, and is regulated with cell type specificity.

Methods

Our goal was to understand TGF-β signaling in regulating SMC differentiation marker expression in human SMC. Activation of Smads was characterized, and loss- and gain-of-function reagents used to define ALK pathways. In addition, Smad-independent mechanisms were determined.

Results

TGF-β type I receptors, ALK1 and ALK5, are expressed in human SMC, and TGF-β1 phosphorylates Smad1/5/8 and Smad2/3 in a time- and dosage-dependent pattern. ALK5 activity, not bone morphogenetic protein type I receptors, is required for Smad phosphorylation. Endoglin, a TGF-β type III receptor, is a TGF-β1 target in SMC, yet endoglin does not modify TGF-β1 responsiveness. ALK5, not ALK1, is required for TGF-β1-induction of SMC differentiation markers, and ALK5 signals through an ALK5/Smad3- and MAP kinase-dependent pathway.

Conclusion

The definition of the specific signaling downstream of TGF-β regulating SMC differentiation markers will contribute to a better understanding of vascular disorders involving changes in SMC phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activin Receptors, Type IIAntigens, CDAortaBone Morphogenetic Protein Receptors, Type ICell DifferentiationCells, CulturedEndoglinGene ExpressionHumansMuscle, Smooth, VascularPhosphorylationProtein Serine-Threonine KinasesReceptor, Transforming Growth Factor-beta Type IReceptors, Cell SurfaceReceptors, Transforming Growth Factor betaSignal TransductionSmad1 ProteinSmad2 ProteinSmad3 ProteinSmad5 Protein

Substanzen

Antigens, CDENG protein, humanEndoglinReceptors, Cell SurfaceReceptors, Transforming Growth Factor betaSMAD1 protein, humanSMAD2 protein, humanSMAD3 protein, humanSMAD5 protein, humanSMAD9 protein, human

Autor:innen und Institutionen

  • Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME 04074, USA.

Förderung

  • NHLBI NIH HHS
  • NCRR NIH HHS

Zitieren

APA

Tang, Y., Yang, X., Friesel, R. E., Vary, C. P., & Liaw, L. (2011). Mechanisms of TGF-β-Induced Differentiation in Human Vascular Smooth Muscle Cells. Journal of Vascular Research, 48(6), 485-494. https://doi.org/10.1159/000327776

Vancouver

Tang Y, Yang X, Friesel RE, Vary CP, Liaw L. Mechanisms of TGF-β-Induced Differentiation in Human Vascular Smooth Muscle Cells. Journal of Vascular Research. 2011;48(6):485-494. doi:10.1159/000327776

BibTeX
@article{Tang2011,
  author = {Tang, Yuefeng and Yang, Xuehui and Friesel, Robert E and Vary, Calvin P H and Liaw, Lucy},
  title = {Mechanisms of TGF-β-Induced Differentiation in Human Vascular Smooth Muscle Cells},
  journal = {Journal of Vascular Research},
  year = {2011},
  volume = {48},
  number = {6},
  pages = {485--494},
  doi = {10.1159/000327776}
}
Kostenlos starten →